ribavirin has been researched along with Foot and Mouth Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Chen, Z; Liang, A; Qiu, R; Shang, H; Sun, Y; Wang, P; Zhang, X; Zhao, C; Zheng, R | 1 |
| Campagnola, G; de Los Santos, T; Diaz-San Segundo, F; Keith, A; Kloc, A; Peersen, O; Rai, DK; Rieder, E; Schafer, EA | 1 |
| Choi, JH; Jeong, K; Kim, B; Kim, SM; Ko, MK; Ku, JM; Lyoo, YS; Park, JH; You, SH | 1 |
| Li, C; Wang, H; Xie, X; Yang, D; Yu, L; Zeng, J; Zhou, G | 2 |
| De Clercq, K; De Vleeschauwer, AR; Goris, N; Kollanur, D; Lefebvre, DJ; Murao, LE; Neyts, J; Osiceanu, AM; Swinnen, J | 1 |
| Agudo, R; Arias, A; de la Higuera, I; Domingo, E; Escarmís, C; Ferrer-Orta, C; Pérez-Luque, R; Sierra, M; Verdaguer, N | 1 |
| Agudo, R; Domingo, E; Manrubia, SC; Perales, C | 1 |
1 review(s) available for ribavirin and Foot and Mouth Disease
| Article | Year |
|---|---|
Clinical features of adverse events associated with Xiyanping-Ribavirin combination: A systematic review.
Topics: Animals; Child; Child, Preschool; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Foot-and-Mouth Disease; Humans; Infant; Infant, Newborn; Pneumonia, Viral; Randomized Controlled Trials as Topic; Ribavirin | 2022 |
7 other study(ies) available for ribavirin and Foot and Mouth Disease
| Article | Year |
|---|---|
Attenuation of Foot-and-Mouth Disease Virus by Engineered Viral Polymerase Fidelity.
Topics: Amino Acid Substitution; Animals; Antigens, Viral; Antiviral Agents; Cells, Cultured; Cricetinae; Disease Models, Animal; DNA Mutational Analysis; Drug Resistance, Viral; Fluorouracil; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Mice; Mutagenesis, Site-Directed; Point Mutation; Protein Engineering; Ribavirin; Swine; Tryptophan; Viral Nonstructural Proteins; Viral Plaque Assay | 2017 |
Synergistic effect of ribavirin and vaccine for protection during early infection stage of foot-and-mouth disease.
Topics: Animals; Antiviral Agents; Cell Line; Drug Synergism; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Injections, Intramuscular; Injections, Intraperitoneal; Mice; Mice, Inbred C57BL; Ribavirin; Swine; Swine, Miniature; Viral Vaccines | 2018 |
Ribavirin-resistant variants of foot-and-mouth disease virus: the effect of restricted quasispecies diversity on viral virulence.
Topics: Animals; Antiviral Agents; Base Sequence; Drug Resistance, Viral; Female; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Genetic Variation; Male; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Mutation, Missense; Ribavirin; RNA-Dependent RNA Polymerase; Viral Proteins; Virulence | 2014 |
In vitro surrogate models to aid in the development of antivirals for the containment of foot-and-mouth disease outbreaks.
Topics: Animals; Antiviral Agents; Aphthovirus; Benzimidazoles; Cattle; Cell Line; Chlorocebus aethiops; Cytidine; Cytopathogenic Effect, Viral; Drug Discovery; Foot-and-Mouth Disease; Models, Theoretical; Oximes; Ribavirin; RNA, Viral; Sulfonamides; Virus Cultivation; Virus Replication | 2014 |
Foot-and-mouth disease virus low-fidelity polymerase mutants are attenuated.
Topics: Animals; Antiviral Agents; Base Sequence; Cell Line; Cricetinae; Drug Resistance, Viral; Fluorouracil; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Mice; Mice, Inbred BALB C; Mutation; Mutation Rate; Ribavirin; RNA-Dependent RNA Polymerase; RNA, Viral; Sequence Analysis, RNA; Virus Replication | 2014 |
Structure of foot-and-mouth disease virus mutant polymerases with reduced sensitivity to ribavirin.
Topics: Amino Acid Sequence; Animals; Catalytic Domain; Cell Line; Cricetinae; DNA-Directed RNA Polymerases; Enzyme Inhibitors; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Molecular Conformation; Molecular Sequence Data; Mutation; Protein Binding; Ribavirin; Viral Proteins | 2010 |
Influence of mutagenesis and viral load on the sustained low-level replication of an RNA virus.
Topics: Animals; Antiviral Agents; Blotting, Western; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Guanidine; Mutagenesis; Mutagens; Mutation; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Messenger; RNA, Viral; Viral Load; Virus Replication | 2011 |